
Researchers provide an update on the adverse events of special interest following patients who received 2024–2025 Pfizer-BioNTech COVID-19 vaccination.
As health care continues to evolve, independent community pharmacists must be flexible and innovative in their business practices to adapt.
Jon Copeland, CEO and president of AAP, recently joined
In the episode, Copeland dives into the following influential factors.
As independent pharmacy forges ahead in 2021 with new responsibilities and challenges, innovation is key.
Listen to the






